Status:

WITHDRAWN

Marker for Stroke Recovery

Lead Sponsor:

Shirley Ryan AbilityLab

Conditions:

Stroke, Ischemic

Eligibility:

All Genders

18-80 years

Brief Summary

This study aims to develop a neurophysiological marker for post-stroke participants that predicts upper extremity motor recovery in response to a standard upper extremity rehabilitation protocol of ta...

Detailed Description

This study aims to develop a neurophysiological marker for post-stroke participants that predicts upper extremity motor recovery in response to a standard upper extremity rehabilitation protocol of ta...

Eligibility Criteria

Inclusion

  • Age from 18 to 80 years
  • Stroke (ischemic subcortical, intermediate level, chronic phase one day to 6 weeks or more from lesion)
  • Clinical and radiological evidence supporting the above diagnoses
  • Chedoke stroke assessment arm stage and hand stage of 3-6 for the affected limb
  • One or more behavioral symptoms possibly linked to the white matter lesion(s)
  • Stable medical condition
  • Normal hearing and (corrected) vision
  • Able to understand and give informed consent
  • English speaker

Exclusion

  • Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
  • Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
  • Surgical clips in the head or previous neurosurgery
  • Any magnetic particles in the body
  • Cochlear implants
  • Prosthetic heart valves
  • Epilepsy or any other type of seizure history
  • History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
  • Significant other disease (heart disease, malignant tumors, mental disorders)
  • Significant claustrophobia; Meniere's disease
  • Pregnancy, breast feeding
  • Medications increasing risk for seizures
  • Non prescribed drug use
  • Failure to perform the behavioral tasks or neuropsychological evaluation tests
  • Prisoners

Key Trial Info

Start Date :

July 30 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 31 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05256368

Start Date

July 30 2022

End Date

August 31 2024

Last Update

June 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shirley Ryan AbilityLab

Chicago, Illinois, United States, 60611